Key result
Managing subacute coronary occlusions requires tailored strategies given their complex position between ACS and CCS.
Why the study?
Subacute coronary occlusions historically have not been well defined, fall in the grey zone between acute and chronic coronary syndromes, pose significant clinical challenges, and require case-by-case assessment.
Design
Review
Subacute coronary occlusions warrant case-by-case strategies in this grey zone; leaves open the need for prospective trials before practice change.
The clinical manifestations and management of obstructive epicardial coronary artery disease vary across acute (acute coronary syndromes) and chronic (chronic coronary syndromes) settings, each with distinct benefits and risks. Most acute occlusions require emergent revascularization to prevent myocardial damage and reduce the risk for major adverse cardiovascular events. Conversely, most symptomatic chronic occlusions are treated with guideline-directed medical therapy while revascularization is reserved to provide symptom relief in those with refractory symptoms despite medical therapy. Subacute coronary occlusions (SCOs), a group that historically has not been well defined, are positioned in the grey zone between these extremes, yet pose significant clinical challenges and require case-by-case assessment. This review explores the nuances of managing SCOs, highlighting the importance of tailored strategies for each clinical context.
No takes yet. Share an insight, caveat, or question.
Alexandrou et al. (2025) studied this question. Management of subacute coronary occlusions requires tailored strategies due to their complex clinical challenges and positioning between acute and chronic coronary syndromes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: